Johns Hopkins Medicine researchers report they have developed and validated a tablet-based app that offers a faster, easier and more accurate way for health care providers who don't have specialized training to assess the cognitive function of people with multiple sclerosis (MS).
Multiple sclerosis is a chronic neurologic illness that affects the central nervous system, resulting in a variety of symptoms including motor issues, fatigue, visual disturbance, memory and concentration concerns, and mood changes. Diagnosis usually occurs between the ages of 20 and 50, and it is estimated that 1 million people in the United States are living with the disease.
App assessment can safe time and produce results more precisely.
Products and exhibitors around mHealth
Exhibitors and products related to these topics can be found in the catalogue of MEDICA 2019:
In a study comparing the app, called iCAMS, to a standard, paper-based assessment tool, researchers say they found that the app produced highly accurate results while reducing test time from about 23 to 14 minutes. Study results are described in the July 2019 online issue of the International Journal of MS Care.
Meghan Beier, Ph.D., assistant professor of physical medicine and rehabilitation at the Johns Hopkins University School of Medicine and lead author of the study report, says that "results suggest that using the iCAMS app may make cognitive assessments of multiple sclerosis more convenient in a clinic setting."
According to Beier, up to 65 percent of people with MS experience cognitive problems. People with MS often require more time to perform mental tasks and face difficulty learning and retaining new information. Identifying cognitive issues earlier may help preserve and even improve function with targeted interventions such as cognitive rehabilitation, says Beier. Since cognitive decline can also be a result of aging, cardiovascular disease, depression and other conditions, specialized assessment tests have been developed to identify MS-related cognitive impairments.
Currently used paper testing tools are time consuming, or specially trained psychometrists must administer them. A study based in the United Kingdom involving the assessment and management of cognitive problems among people with MS shows that only 8 percent of MS specialists are using MS-validated cognition assessment tools.
In a bid to improve that record, Beier and her team adapted an internationally validated cognitive assessment tool for MS patients, called the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS), to a digital tablet format. BICAMS, composed of three subtests, measures processing speed, or how fast the brain can take in and process environmental information such as recognizing a stoplight and sending a signal to the foot to push the brake; the ability to learn verbal information, such as remembering key aspects of the story a family member told; and the ability to learn visual information, such as creating a mental map of a hotel the person is visiting.
Study participants included 100 adults from the University of Washington Medicine Multiple Sclerosis Center who had a physician-confirmed MS diagnosis. Participants were between the ages of 18 and 79. The patients had MS for an average of 10 to 11 years, and 78 percent had relapsing-remitting MS, the most common form of the disorder.
Trained research assistants administered paper and iPad tests to participants. Half of the sessions were led by an administrator who provided the paper test, and the other half of the group received an iCAMS tablet test.
When researchers compared the test scores for each participant, the answers were the same 93 percent of the time, validating the accuracy of the app-based test, they say. Furthermore, the administration and scoring time for the app-based test was 40 percent shorter than the paper version.
Beier says that in addition to saving time and being easier to administer, a tablet-based test eliminates the need to store paper-based records and makes sharing information easier on electronic medical records. The app may also reduce the rate of errors in calculating and transferring scores.
"Our goal is to reduce barriers for patients to receive the testing that may benefit their treatment and health through the use of digital technology," adds Abbey Hughes, Ph.D., assistant professor of physical medicine and rehabilitation at the Johns Hopkins University School of Medicine and co-author of the study.
MEDICA-tradefair.com; Source: Johns Hopkins Medicine